EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $616,000 | -20.9% | 30,700 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $779,000 | +3.0% | 31,851 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $756,000 | +37.0% | 31,851 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $552,000 | -36.0% | 32,040 | -34.6% | 0.00% | 0.0% |
| Q4 2019 | $863,000 | -0.5% | 48,981 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $867,000 | -29.5% | 48,981 | -14.9% | 0.00% | 0.0% |
| Q2 2019 | $1,230,000 | -70.7% | 57,560 | -67.3% | 0.00% | -83.3% |
| Q1 2019 | $4,193,000 | +241.4% | 176,193 | +182.1% | 0.01% | +500.0% |
| Q4 2018 | $1,228,000 | +212.5% | 62,460 | +181.7% | 0.00% | 0.0% |
| Q3 2018 | $393,000 | -74.3% | 22,169 | -68.9% | 0.00% | -50.0% |
| Q2 2018 | $1,532,000 | +364.2% | 71,200 | +377.9% | 0.00% | +100.0% |
| Q1 2018 | $330,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |